Wegovy vs Mounjaro: Which Weight Management Option?
Changing From Wegovy to Mounjaro: UK Online Comparison
When changing from Wegovy to Mounjaro, understanding the fundamental differences helps inform your decision. Wegovy contains semaglutide, a GLP-1 receptor agonist, while Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist. This means Mounjaro targets two hormone pathways compared to Wegovy's single pathway approach. EverydayMeds provides both options through our GPhC-registered online pharmacy (#9012878), allowing you to access either treatment with proper clinical assessment.
The practical considerations when changing from Wegovy to Mounjaro extend beyond just the mechanism of action. Dosing schedules differ between the treatments, with Wegovy following a structured 0.25mg to 2.4mg escalation over 16 weeks, while Mounjaro uses a different titration approach. Both are prescription-only medicines requiring clinical assessment, but the transition process should be carefully managed with prescriber guidance. Our online platform makes accessing either treatment straightforward, with next-day delivery available once your prescription is approved.
Wegovy Pricing and Value When Comparing to Mounjaro
For patients changing from Wegovy to Mounjaro considerations, price often plays a significant role in treatment selection. Wegovy at EverydayMeds starts from £79.99 for the 0.25mg starter dose using discount code FIRST40, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Returning customers can use code DOSE25 at checkout for continued savings. Our bundle options provide convenient multi-month supplies, such as the Intro Trio covering your first 12 weeks for £299.99.
When evaluating changing from Wegovy to Mounjaro costs, consider the long-term financial commitment alongside clinical factors. Both treatments require ongoing use to maintain weight management benefits, as demonstrated in STEP trial extensions where patients regained approximately two-thirds of lost weight within one year of discontinuation. EverydayMeds offers transparent pricing for both options, allowing direct cost comparison alongside clinical considerations. Our Consistency bundles provide two pens of the same dose, ideal for patients established on their maintenance dose who want to secure their supply.
Clinical Evidence Supporting Wegovy in Treatment Decisions
In clinical trials, patients taking Wegovy alongside diet and exercise achieved significant weight management outcomes. The STEP 1 trial demonstrated approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, while STEP 2 showed clinically studied weight loss in patients with type 2 diabetes. These outcomes inform many patients' decisions when changing from Wegovy to Mounjaro comparisons.
The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events (HR 0.80) with semaglutide, providing additional clinical context beyond weight management alone. However, both Wegovy and Mounjaro have demonstrated efficacy in their respective clinical programmes, making the choice between treatments highly individualised. Your prescriber can help interpret these trial results in the context of your specific health profile when considering changing from Wegovy to Mounjaro options.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone called glucagon-like peptide-1. This hormone is normally released by your intestines after eating and signals to your brain that you're becoming full. By activating GLP-1 receptors, Wegovy may help reduce appetite and promote feelings of satiety after smaller meals. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged fullness. Additionally, Wegovy may help reduce food cravings by working on appetite centres in the brain, though individual responses can vary significantly.
Ordering Process for Wegovy When Changing From Mounjaro
Accessing Wegovy when changing from Wegovy to Mounjaro involves a straightforward three-step process at EverydayMeds. First, complete our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Next, our prescribers review your assessment alongside your previous Mounjaro experience to determine suitability - standard review takes 3 working days, or express 24-hour service is available. Finally, once approved, your Wegovy is dispatched for next-day delivery in temperature-controlled packaging to maintain medication integrity. Our cold-chain logistics ensure your medication arrives in optimal condition regardless of weather conditions across the UK.
Storage and Practical Considerations: Wegovy vs Mounjaro
When changing from Wegovy to Mounjaro, storage requirements represent a key practical difference between these treatments. Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. This gives Wegovy a significant advantage for travel or situations where refrigeration isn't consistently available. Both medications arrive in their respective pen injectors - Wegovy uses Novo Nordisk's FlexTouch pen system, administered once weekly on the same day each week. The dose escalation schedule for Wegovy is structured over 16 weeks, starting at 0.25mg and gradually increasing to the 2.4mg maintenance dose to minimise side effects.
Making the Switch: Unique Considerations for UK Patients
Patients changing from Wegovy to Mounjaro in the UK should consider NHS vs private pathway implications. While both treatments have NICE recommendations under specific circumstances (TA875 for Wegovy), accessing either through private online pharmacies like EverydayMeds provides greater flexibility and shorter waiting times. The transition process requires careful timing to avoid treatment gaps that might affect your weight management progress.
Regulatory oversight differs between these medications, with both subject to MHRA additional monitoring marked by the Black Triangle (▼) symbol. This enhanced monitoring reflects their relatively recent introduction to the UK market rather than safety concerns. When changing from Wegovy to Mounjaro, your treatment history with either medication provides valuable data for prescribers making clinical decisions about your ongoing weight management strategy.
Start Your Wegovy Journey: Next Steps and Expert Support
Ready to explore changing from Wegovy to Mounjaro options or begin with Wegovy? Visit https://everydaymeds.co.uk/collections/wegovy to start your clinical assessment today. New customers can apply discount code FIRST40 at checkout, while returning customers use DOSE25 for continued savings on their weight management journey. Our clinical team provides ongoing support throughout your treatment, with prescriber reviews available for dose adjustments or addressing any concerns. Remember that both Wegovy and Mounjaro must be used alongside a reduced-calorie diet and increased physical activity for optimal results. As a GPhC-registered pharmacy (#9012878), EverydayMeds maintains the highest standards of pharmaceutical care while making these important treatments accessible across the UK.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
